← SynDRA
ZOXAZOLAMINE
SynDRA canonical compound SYN0011643 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Mechanism of action | myorelaxant |
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX15
- CBX1
- THRB
- TDP1
- TARDBP
- SLCO1B3
- SLCO1B1
- NFE2L2
- MAPT
- MAPK1
- LMNA
- HSPA5
- HMBS
- HDAC6
- GALC
- FECH
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Antirheumatic Agents
- Central Nervous System Agents
- Gout Suppressants
- Muscle Relaxants, Central
- Neuromuscular Agents
- Peripheral Nervous System Agents
- Uricosuric Agents
- myorelaxant
Cross-references
Synonyms
- 5-Chloro-2-aminobenzoxazole
- deflexol
- flexilon
- zoxamin
- zoxine
- Zoxazolamina
- Contrazole
- Deflexol
- Flexin
- Miazol
- Uri-boi
- Zoxamine
- Zoxine
- MCN-485
- NSC-24995
- 2-Amino-5-chlorobenzoxazole
- 5-chlorobenzo[d]oxazol-2-amine
- 5-Chloro-1,3-benzoxazol-2-amine
- 2-Benzoxazolamine, 5-chloro-
- Flexilon
- Zoxamin
- USAF MA-12
- McN-485
- 5-Chloro-2-benzoxazolamine
- Zossazolamina [DCIT]
- C7H5ClN2O
- Zoxazolaminum [INN-Latin]
- Zoxazolamina [INN-Spanish]
- NSC 24995
- UNII-9DOW362Q29
- BENZOXAZOLE, 2-AMINO-5-CHLORO-
- CHEBI:35053
- EINECS 200-519-4
- MLS002639033
- AI3-63120
- YGCODSQDUUUKIV-UHFFFAOYSA-N
- 9DOW362Q29
- 2-Amino-5-chlorobenzoxazole, 97%
Look up ZOXAZOLAMINE in the interactive SynDRA portal →